Efficacy and safety study of the antihistamine V0114CP 2.5MG in the treatment of perennial allergic rhinitis. Randomised, double blind, tree arm parallel group study including placebo and active control
Efficacy and safety study of the antihistamine V0114CP 2.5MG in the treatment of perennial allergic rhinitis. Randomised, double blind, tree arm parallel group study including placebo and active control
Efficacy and safety study of the antihistamine V0114CP 2.5MG in the treatment of perennial allergic rhinitis. Randomised, double blind, tree arm parallel group study including placebo and active control
Status
Status :
Completed
Type of study
Phase III
Min. Age
18
Years old
Max. Age
-
Gender
All
Therapeutic area :
Allergy
Disease :
Allergic rhinitis
Study medication :
L-mequitazine (Xyzall®)
Phase :
Phase III
Start Date :
13 February 2008
End date :
27 August 2009
Study ID :
V00114 CP 302 2A
EudraCT/CTIS number :
2007-003572-19
Send by email